Literature DB >> 26710875

[Effect of Toll-like receptor 4 signaling activation on the biological behavior of gastric cancer cell lines].

Nina Wang, Di An, Qian Li, Chao Li, Guibin Yang.   

Abstract

OBJECTIVE: To investigate the effects of Toll like receptor (TLR) signaling activation on the malignant biological behavior of gastric cancer cell lines.
METHODS: RT-PCR was employed to detect the basal expression of TLRs in the gastric cancer cell lines. According to the basal RNA expression, the proteic expression of TLR4 of the cell lines was examined using Western blot analysis. BGC823 and AGS cell lines were chosen for investigating the effects of TLR4 signaling activation on the biological behavior due to the high level of TLR4 proteic expression.
RESULTS: TLR4 RNA expression was higher than any other TLRs in the gastric cancer cell lines. Higher relative proteic expression of TLR4 was observed in BGC823 (1. 41 ± 0. 05) and AGS (1. 22 ± 0. 05) (all P <0. 05). Activation of the TLR4 signaling pathway by LPS increased proliferation, migration and invasion of BGC823 and AGS cell lines (all P < 0. 05).
CONCLUSION: TLR4 may participate in the metastasis of gastric cancer through promotes the malignant biological behavior of gastric cancer cell, and may be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26710875

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome.

Authors:  Aaro Kasurinen; Jaana Hagström; Alli Laitinen; Arto Kokkola; Camilla Böckelman; Caj Haglund
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

2.  The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer.

Authors:  Heikki Huhta; Olli Helminen; Joonas H Kauppila; Tuula Salo; Katja Porvari; Juha Saarnio; Petri P Lehenkari; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2016-07-01       Impact factor: 2.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.